Medtide (3880 HK)

Medtide is a China-based, peptide-focused contract research, development, and manufacturing organization (CRDMO). It offers full-cycle services from early-stage discovery, preclinical research, and clinical development to commercial-stage production of peptide new chemical entities (NCEs) and active pharmaceutical ingredients (APIs). The company was founded in 2020 and is headquartered in Hangzhou, China.